Sarepta Therapeutics Inc. | Key People and Executives
Douglas S. Ingram
President, Chief Executive Officer & Director
M. Kathleen Behrens
Chairman
Michael W. Bonney
Independent Director
Claude Nicaise
Independent Director
Richard Jon Barry
Independent Director
Hans Lennart Rudolf Wigzell
Independent Director
Douglas S. Ingram
President, Chief Executive Officer & Director
Sandesh Mahatme
Executive VP, Chief Financial & Business Officer
Gilmore O’Neill
Chief Medical Officer & Senior Vice President
Guriqbal S. Basi
Chief Scientific Officer
Alexander Cumbo
Chief Commercial Officer & Senior Vice President
Diane Berry
VP-Global Health Policy & Government Affairs
Ian Estepan
Head-Investor & Media Relations
Joan Nickerson
Vice President-Human Resources
David Tyronne Howton
Secretary, Senior Vice President & General Counsel
Shamim Ruff
Chief Regulatory Affairs Officer & Senior VP
M. Kathleen Behrens
Chairman
Michael W. Bonney
Independent Director
Claude Nicaise
Independent Director
Richard Jon Barry
Independent Director
Hans Lennart Rudolf Wigzell
Independent Director
| Address |
215 First Street
Cambridge Massachusetts 02142
United States
|
|
Employees
|
- |
| Website |
http://www.sareptatherapeutics.com |
| Updated |
07/08/2019 |
| Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare neuromuscular diseases. It focuses on the development of its potentially disease-modifying Duchenne Muscular Dystrophy drug candidates. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA. |
